KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Revenue (2016 - 2025)

Historic Revenue for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q4 2025 value amounting to $864000.0.

  • CRISPR Therapeutics AG's Revenue fell 9757.92% to $864000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 million, marking a year-over-year decrease of 9059.33%. This contributed to the annual value of $3.5 million for FY2025, which is 9059.33% down from last year.
  • According to the latest figures from Q4 2025, CRISPR Therapeutics AG's Revenue is $864000.0, which was down 9757.92% from $889000.0 recorded in Q3 2025.
  • CRISPR Therapeutics AG's Revenue's 5-year high stood at $900.7 million during Q2 2021, with a 5-year trough of $6000.0 in Q4 2022.
  • Over the past 5 years, CRISPR Therapeutics AG's median Revenue value was $865000.0 (recorded in 2025), while the average stood at $69.9 million.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 9998.25% in 2022, then skyrocketed by 335333333.33% in 2023.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Revenue stood at $12.9 million in 2021, then tumbled by 99.95% to $6000.0 in 2022, then surged by 3353333.33% to $201.2 million in 2023, then tumbled by 82.26% to $35.7 million in 2024, then crashed by 97.58% to $864000.0 in 2025.
  • Its last three reported values are $864000.0 in Q4 2025, $889000.0 for Q3 2025, and $892000.0 during Q2 2025.